Molecular Requirements for the Expression of Antiplatelet Effects by Synthetic Structural Optimized Analogues of the Anticancer Drugs Imatinib and Nilotinib
Pantazi, Despoina, Ntemou, Nikoleta, Brentas, Alexios, Alivertis, Dimitrios, Skobridis, Konstantinos, Tselepis, Alexandros DVolume:
Volume 13
Language:
english
Journal:
Drug Design, Development and Therapy
DOI:
10.2147/DDDT.S211907
Date:
December, 2019
File:
PDF, 10.47 MB
english, 2019